Ipilimumab treatment results in an early decrease in the frequency of circulating granulocytic myeloid derived suppressor cells as well as their arginase1 production

Samankaltaisia teoksia

• Ipilimumab treatment decreases circulating Tregs and GrMDSC while enhancing CD4+ T cell activation
  Tekijä: Pico de Coaña, Yago, et al.
  Julkaistu: (2015)
• Ipilimumab treatment enhances CD4+ T cell activation while decreasing Treg and MDSC frequency in advanced melanoma patients
  Tekijä: Pico de Coaña, Yago, et al.
  Julkaistu: (2014)
• Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma
  Tekijä: de Coaña, Yago Pico, et al.
  Julkaistu: (2017)
• Inhibiton of tumor-derived prostaglandin-e2 prevents the induction of human myeloid-derived suppressor cells (MDSCs) and rescues anti-tumor immunity
  Tekijä: Mao, Yumeng, et al.
  Julkaistu: (2014)
• Arginase I–Producing Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma Are a Subpopulation of Activated Granulocytes
  Tekijä: Rodriguez, Paulo C., et al.
  Julkaistu: (2009)